Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.

about

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.

Item

http://www.wikidata.org/entity/Q38711090

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.

@en

type

Item

label

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.

@en

prefLabel

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.

@en

P1476

Potential Antitumor Activity of SIM-89 in Non-Small Cell Lung Cancer Cells.

@en

P2093

Aiqing Gu

http://www.w3.org/2001/XMLSchema#string

Baohui Han

http://www.w3.org/2001/XMLSchema#string

Huifang Sha

http://www.w3.org/2001/XMLSchema#string

Jiajun Teng

http://www.w3.org/2001/XMLSchema#string

Jialin Qian

http://www.w3.org/2001/XMLSchema#string

Jun Pei

http://www.w3.org/2001/XMLSchema#string

Minhua Shao

http://www.w3.org/2001/XMLSchema#string

Rong Li

http://www.w3.org/2001/XMLSchema#string

Tianqing Chu

http://www.w3.org/2001/XMLSchema#string

Weifeng Mao

http://www.w3.org/2001/XMLSchema#string

P2860

The MET axis as a therapeutic target.

Met, metastasis, motility and more

Invasive growth: a MET-driven genetic programme for cancer and stem cells

Co-overexpression of Met and hepatocyte growth factor promotes systemic metastasis in NCI-H460 non-small cell lung carcinoma cells.

The MET receptor tyrosine kinase is a potential novel therapeutic target for head and neck squamous cell carcinoma.

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.

Drug development of MET inhibitors: targeting oncogene addiction and expedience.

The role of the c-Met pathway in lung cancer and the potential for targeted therapy.

c-Met gene amplification is associated with advanced stage colorectal cancer and liver metastases.

Hepatocyte growth factor enhances vascular endothelial growth factor-induced angiogenesis in vitro and in vivo.

P304

581-591

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2017.58.3.581

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28332364

http://www.w3.org/2001/XMLSchema#string

P932

5368144

http://www.w3.org/2001/XMLSchema#string